70 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization, and (iv) the recorded … and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
common stock and/or warrants may be delisted and the price of our common stock and/or warrants and our ability to access the capital markets could … also may access these filings on our website at www.processapharmaceuticals.com. We do not incorporate the information on our website
8-K
EX-3.1
7ik2x1e u33blb
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
8-K
EX-10.1
ukiwbj j3dbu
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
424B5
tqogxysx8o8r8d
24 Mar 22
Prospectus supplement for primary offering
4:15pm